Sector: MedicalOMRIX BIOPHARMACEUTI (NASDAQ: OMRI)
Headlines
- King Beats, But Earnings Down
Nov 05, 2009 04:13 PM | ALO, CEPH, KG, OMRI, PTIE, ZGEN
- Top 40 Rated Emerging Bio-Pharma Stocks
Dec 22, 2008 12:27 PM | ABT, AUXL, BMY, EBS, EXEL, ISIS
- Periodicals Wrap-Up for Monday, August 18
Aug 18, 2008 09:50 AM | AAPL, ADBE, AGU, ANF, ANN, APOL
- QLT Inc. announces agreement for sale of real estate and Geron shares recover after drop on study delay
May 16, 2008 09:29 AM | OMRI, QLTI
- NASDAQ Technical Picture - Lowest Close Since Oct. 2006 - Mar 7 2008 10:05AM
Mar 07, 2008 10:05 AM | ABM, ADSK, AMSC, ASGN, ASTE, BBI
- NASDAQ Technical Picture - Lowest Close Since Oct. 2006 - Mar 2 2008 11:12PM
Mar 02, 2008 11:11 PM | ABM, ADSK, AMSC, ASGN, ASTE, BBI
- Another Swift Recovery?
Feb 04, 2008 10:25 AM | ACGY, ADM, BEAV, BRCM, BRLC, CERS
- UPDATE: Look For Small-cap Growth To Outperform In 2008
Jan 07, 2008 12:28 AM | OMRI
- FDA Approves Anti-Bleeding Product From Omrix
Aug 28, 2007 11:07 AM | JNJ, OMRI
- Omrix Biopharma (NASDAQ:OMRI): Oppenheimer upgrades to Buy
Aug 09, 2007 12:06 PM | OMRI
- Johnson & Johnson Completes Tender Offer for Omrix Biopharmaceuticals, Inc.
Dec 27, 2008 10:09 AM | JNJ, OMRI
- Johnson & Johnson Extends Tender Offer for Omrix Biopharmaceuticals, Inc.
Dec 19, 2008 05:43 PM | JNJ, OMRI
- Johnson & Johnson Announces Receipt of Israeli Antitrust Approval for Acquisition of Omrix
Dec 11, 2008 05:41 PM | JNJ, OMRI
- Law Offices of Brian M. Felgoise, P.C. Announces Class Action Lawsuit on Behalf of Shareholders of Omrix Biopharmaceuticals, Inc. -- OMRI
Dec 03, 2008 01:46 PM | OMRI
- Johnson & Johnson Begins Tender Offer to Acquire Omrix
Nov 25, 2008 12:39 PM | JNJ, OMRI
- Johnson & Johnson Announces Definitive Agreement to Acquire Omrix
Nov 24, 2008 06:31 AM | JNJ, OMRI
- Omrix Biopharmaceuticals to Webcast Presentation at Credit Suisse Annual Healthcare Conference
Nov 06, 2008 01:48 PM | OMRI
- Omrix Biopharmaceuticals Announces Third Quarter 2008 Financial Results
Nov 06, 2008 07:14 AM | OMRI
- Omrix Biopharmaceuticals to Webcast Presentation at Rodman & Renshaw Annual Healthcare Conference
Nov 04, 2008 08:23 AM | OMRI
- Omrix Biopharmaceuticals Reschedules its Third Quarter 2008 Financial Results and Conference Call to an Earlier Time on November 6, 2008
Nov 03, 2008 08:33 AM | OMRI
- Form 4 Taub Robert For: Nov 23 (10K)
Nov 25, 2008 01:38 PM
- Form 3 Omrix Biopharmaceuticals For: Oct 23 Filed by: Alperovitz Asaf (10K)
Nov 05, 2008 05:18 PM
- Form 4 Omrix Biopharmaceuticals For: Oct 10 Filed by: Mashiach Nissim (10K)
Oct 30, 2008 06:05 PM
- Form 4 Omrix Biopharmaceuticals For: Sep 04 Filed by: Taub Robert (10K)
Sep 05, 2008 05:11 PM
- Form 4 Omrix Biopharmaceuticals For: Sep 04 Filed by: St Peter Steven (10K)
Sep 05, 2008 05:07 PM
- Form 4 Omrix Biopharmaceuticals For: Sep 04 Filed by: Romagnoli Philippe (10K)
Sep 05, 2008 05:07 PM
- Form 4 Omrix Biopharmaceuticals For: Sep 04 Filed by: RAKIN KEVIN (10K)
Sep 05, 2008 05:04 PM
- Form 4 Omrix Biopharmaceuticals For: Sep 04 Filed by: Horowitz Bernard (10K)
Sep 05, 2008 05:04 PM
- Form 4 Omrix Biopharmaceuticals For: Sep 04 Filed by: ELLBERGER LARRY (10K)
Sep 05, 2008 05:04 PM
- Form 4 Omrix Biopharmaceuticals For: May 15 Filed by: MCNAMARA PAMELA W (10K)
May 30, 2008 12:25 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
OMRI
|
Compare to S&P
|
| YTD |
-0.01 %
|
20.97 %
|
| 4 Weeks |
-0.01 %
|
-0.01 %
|
| 12 Weeks |
-0.01 %
|
-0.01 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 23.53 %
|
|
EPS Growth in Last Year: 0.00 %
|
|
Sales Growth in Last Quarter: 10.69 %
|
|
Sales Growth in Last Quarter: 34.27 %
|
|
